Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H10FN3 |
Molecular Weight | 262.2716 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[18F]C1=NC=C(C=C1)C2=CC3=C(C=C2)C4=C(N3)C=CN=C4
InChI
InChIKey=GETAAWDSFUCLBS-SJPDSGJFSA-N
InChI=1S/C16H10FN3/c17-16-4-2-11(8-19-16)10-1-3-12-13-9-18-6-5-14(13)20-15(12)7-10/h1-9,20H/i17-1
Molecular Formula | C16H10FN3 |
Molecular Weight | 262.2716 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Flortaucipir (18F-AV-1451, also known as 18F-T807) is a highly selective positron emission tomography (PET) imaging agent targeting paired helical filament (PHF)-tau in the brain. This tracer is studying for clinical assessment in patients with various tauopathies, including Alzheimer's disease, as well as in healthy subjects.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. | 2013 Nov |
|
Synthesis and quality control of [(18) F]T807 for tau PET imaging. | 2016 Aug |
|
Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease. | 2016 Oct |
|
Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia. | 2017 Apr-Jun |
|
Quantification of Tau Load Using [(18)F]AV1451 PET. | 2017 Dec |
|
Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden. | 2017 Dec 1 |
|
Tau PET imaging: present and future directions. | 2017 Feb 20 |
|
Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex. | 2017 Jul 1 |
|
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. | 2017 Mar 1 |
|
(18) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study. | 2017 Oct |
|
(18)F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease. | 2018 Feb |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28077397
Flortaucipir PET images were acquired for 20 min, as four 5-min frames, beginning 80 min after injection of 370 MBq flortaucipir. On a separate day, subjects underwent a florbetapir PET scan for 10 min, as two 5-min frames, beginning 50 min after injection of 370 MBq florbetapir F18.
Route of Administration:
Parenteral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:53:51 GMT 2023
by
admin
on
Sat Dec 16 09:53:51 GMT 2023
|
Record UNII |
T1JP1KYU9O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
70957463
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
DB14914
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
Flortaucipir (18F)
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
m12220
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
CD-33
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
1522051-90-6
Created by
admin on Sat Dec 16 09:53:51 GMT 2023 , Edited by admin on Sat Dec 16 09:53:51 GMT 2023
|
PRIMARY | |||
|
DTXSID001027893
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
10203
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
100000178384
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
T1JP1KYU9O
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
CHEMBL3546271
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
T1JP1KYU9O
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
2372689
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY | |||
|
C171887
Created by
admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->RADIOLIGAND |
Images aggregates
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|